Frontlight ResearchEarly access
Ulcerative colitis trials in United States
86 of 111 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 4Enrolling by invitationINSIGHT-IBD Pragmatic Study
- Where
- Cedar Park, Fort Worth, Glenview, Gurnee, Houston, Indianapolis, Plano, Richmond, Rochester, San Antonio, San Marcos, Sun City, Tucson
- Age
- 21 years and over
- People
- 400
- Run by
- Specialty Networks Research.
See details and how to joinNCT07686757 - Phase 4Taking peopleA Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Where
- Albuquerque, Atlanta, Baton Rouge, Bellevue, Birmingham, Bridgeton, Brooksville, Carmel, Cedarhurst, Chandler, Charlotte, Chevy Chase, Cincinnati, Clearwater, Colorado Springs, Columbia, Crestview Hills, Dayton, Decatur, Downers Grove, Elmhurst, El Paso, Escondido, Framingham, Fresh Meadows, Georgetown, Gilbert, Glen Burnie, Glenview, Greenville, Hialeah, Houston, Hutchinson, Kansas City, Katy, Kingsport, Kingwood, Kissimmee, Lafayette, Lake Barrington, Lake Success, Liberty Township, Little Rock, Littleton, Lubbock, Mentor, Metairie, Miami, Mobile, Murrieta, Naperville, New Bedford, Newport Beach, New York, Oak Lawn, Ogden, Orange, Orlando, Pensacola, Pinehurst, Pinellas Park, Plymouth, Portland, Providence, Reno, Roanoke, Rochester, Rockford, San Diego, Seaford, Sioux Falls, Southaven, Springboro, Springfield, Statesville, Suffolk, Summerville, Sun City, Syracuse, Tomball, Utica, Waco, Webster, Weldon Spring, Westfield, Westlake, West Nyack, Williamsburg, Wilmington, Wyoming, Ypsilanti
- Age
- 18 years to 80 years
- People
- 200
- Run by
- Takeda
See details and how to joinNCT06581328 - Phase 2Taking peopleA Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Where
- Abilene, Boston, Chicago, Cleveland, Fort Worth, Garden Grove, Little Rock, Loma Linda, Orlando, Royal Oak, San Bernardino, San Francisco
- Age
- 12 years to 17 years
- People
- 36 worldwide
- Run by
- Pfizer
See details and how to joinNCT05287126 · EU 2022-500345-25-00 - Phase 2Taking peopleA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Where
- Chicago, Colorado Springs, Fresh Meadows, Kissimmee, Lancaster, Monroe, Rochester, Salt Lake City, San Diego
- Age
- 18 years and over
- People
- 224 worldwide
- Run by
- Genentech, Inc.
See details and how to joinNCT06979336 · EU 2025-520690-39-00 - Phase 3Taking peopleA Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Where
- Atlanta, Chicago, Cleveland, Dallas, Greenville, Miami, Morristown, Philadelphia, Phoenix, Pittsburgh, San Diego, San Francisco
- Age
- 2 years to 17 years
- People
- 120 worldwide
- Run by
- AbbVie
See details and how to joinNCT07071519 · EU 2024-514695-41-00 - Phase 2Taking peopleStudy of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Where
- Anaheim, Asheville, Beavercreek, Bellaire, Bellevue, Boise, Bradenton, Colorado Springs, Coronado, Des Plaines, Dothan, Flowood, Fort Worth, Garland, Georgetown, Glenview, Greenville, Gurnee, Houston, Kissimmee, Knoxville, Lancaster, Lansdowne Town Center, Largo, Las Vegas, Los Alamitos, Louisville, Lubbock, Macon, Mandeville, Mansfield, Memphis, Metairie, Miami, Milwaukee, New Albany, New Bedford, New Port Richey, New York, Oak Lawn, Orlando, Oxford, Phoenix, Providence, Rialto, Richmond, Roswell, San Antonio, Shenandoah, Shreveport, Southlake, St Louis, Sun City, Tacoma, Tampa, Tyler, Vancouver, Webster, Westlake, Wyoming
- Age
- 18 years to 75 years
- People
- 2,000 worldwide
- Run by
- AbbVie
See details and how to joinNCT07697456 · EU 2026-525959-86-00 - Phase 2Taking peopleA Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
- Where
- Indianapolis, New York
- Age
- 2 years to 11 years
- People
- 24 worldwide
- Run by
- Pfizer
See details and how to joinNCT07470879 · EU 2025-523100-77-00 - Phase 3Taking peopleA Study to Assess the Efficacy and Safety of Subcutaneous Induction Therapy With Afimkibart in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Cordova
- Age
- 16 years to 80 years
- People
- 350
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07846683 · EU 2026-526684-37-00 - No phaseTaking peopleHyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Where
- Birmingham, Boston, Lake Forest, Lebanon, Los Angeles, Louisville, Miami, New York, Orlando, Pittsburgh, Rochester, Syracuse
- Age
- 18 years to 85 years
- People
- 126
- Run by
- Northwestern University
See details and how to joinNCT05987852 - Phase 3Taking peopleAn Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Arcadia, Atlanta, Aurora, Baltimore, Baton Rouge, Baytown, Bellevue, Boston, Canoga Park, Canton, Chapel Hill, Charlotte, Chesterfield, Chicago, Clermont, Clive, Colorado Springs, Columbus, Coral Springs, Cordova, Coronado, Dallas, Dayton, Denver, Des Plaines, Durham, East Orange, Fargo, Fayetteville, Folsom, Freehold, Gainesville, Glenview, Greenbelt, Gurnee, Harlingen, Hershey, Houma, Idaho Falls, Jackson, Kansas City, Kingwood, Kissimmee, Lake Jackson, Lancaster, Las Vegas, Lexington, Liberty, Little Rock, Los Angeles, Lubbock, Lynchburg, Mandeville, Marrero, Maspeth, Mesquite, Metairie, Miami, Monroe, Morristown, Murrieta, New Albany, New Haven, New Iberia, New York, Norman, Orlando, Oxnard, Palmetto Bay, Peoria, Philadelphia, Pittsburgh, Portland, Providence, Raleigh, Richmond, Sacramento, San Antonio, San Diego, Sandy Springs, Santa Maria, Scottsdale, Snellville, Somers Point, Southlake, Sparta, Springboro, Suwanee, Tampa, Tarzana, The Bronx, Thousand Oaks, Toledo, Tomball, Tucson, Tyler, Valencia, Vancouver, Victorville, Waterloo, West Columbia, West Jordan, Westlake, Worcester, Wyoming
- Age
- 16 years to 80 years
- People
- 980 worldwide
- Run by
- Sanofi
See details and how to joinNCT07184996 - Phase 2Taking peopleConfirmatory Clinical Study in Active Ulcerative Colitis
- Where
- Fayetteville, High Point, Miami, Orlando, Palmetto Bay, San Antonio
- Age
- 16 years and over
- People
- 204 worldwide
- Run by
- MRM Health NV
See details and how to joinNCT07296315 · EU 2025-524682-24-00 - Phase 1Taking peopleSafety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Crohn's Disease or Ulcerative Colitis
- Where
- Naples
- People
- 15 worldwide
- Run by
- The Foundation for Orthopaedics and Regenerative Medicine
See details and how to joinNCT05003947 - Phase 2/3Taking peopleA Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Where
- Atlanta, Boston, Chapel Hill, Charleston, Charlotte, Cleveland, Detroit, Fort Worth, Garden Grove, Hartford, Hershey, Houston, Indianapolis, Iowa City, Loma Linda, Los Angeles, Milwaukee, New York, Oklahoma City, Orlando, Palo Alto, Park Ridge, Phoenix, Portland, Rochester, Sacramento, Seattle, Springfield, St Louis, Tacoma, Tucson, Washington D.C., Worcester
- Age
- 2 years to 17 years
- People
- 120 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05076175 - No phaseTaking peopleSTOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
- Where
- Chicago
- Age
- 18 years to 75 years
- People
- 200
- Run by
- University of Chicago
See details and how to joinNCT06693310 - Phase 3Taking peopleA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Atlanta, Baton Rouge, Chesterfield, Colorado Springs, Columbus, Coronado, Fayetteville, Gurnee, Idaho Falls, Kingwood, Kissimmee, Lexington, Liberty, Lubbock, Mandeville, Maspeth, Miami, Monroe, Murrieta, New Albany, New York, Pittsburgh, Providence, San Antonio, Southlake, Sparta, Tampa, Tucson, Tyler, Vancouver, Victorville, Westlake, Worcester, Wyoming
- Age
- 16 years to 80 years
- People
- 751 worldwide
- Run by
- Sanofi
See details and how to joinNCT07185009 - Phase 3Taking peopleA Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Where
- Atlanta, Boston, Fairfax, Fort Worth, Hartford, New York, Philadelphia, San Francisco, St Louis, Waltham
- Age
- 2 years to 19 years
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT04844606 - No phaseTaking peopleKetogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis
- Where
- Charlottesville
- Age
- 18 years to 64 years
- People
- 160
- Run by
- Fuller Research Foundation
See details and how to joinNCT07524244 - Phase 4Not yet taking people in United StatesCombination CurQD and Vedolizumab in Ulcerative Colitis
- Where
- New York
- Age
- 18 years to 80 years
- People
- 160 worldwide
- Run by
- Ryan C Ungaro
See details and how to joinNCT07665294 - No phaseNot yet taking people in United StatesThe EDICT Trial - Therapy for Inflammatory Bowel Disease Flares
- Where
- Winston-Salem
- Age
- 21 years and over
- People
- 42
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT07143188 - Phase 4Not yet taking people in United StatesUpadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis
- Where
- San Francisco
- Age
- 18 years to 75 years
- People
- 50
- Run by
- University of California, San Francisco
See details and how to joinNCT07502339 - Phase 2Taking peopleProof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Where
- Cleveland, Miami, Roswell, Tampa
- Age
- 18 years to 75 years
- People
- 120 worldwide
- Run by
- Athos Therapeutics Inc
See details and how to joinNCT07513181 · EU 2024-520183-33-00 - Phase 1Taking peopleA Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis
- Where
- Miami
- Age
- 18 years to 55 years
- People
- 90
- Run by
- Ono Pharmaceutical Co., Ltd.
See details and how to joinNCT07749768 - No phaseNot yet taking people in United StatesVirtual Group Therapy for IBD Patients With Anxiety and Depression
- Where
- Chicago
- Age
- 18 years and over
- People
- 16
- Run by
- University of Chicago
See details and how to joinNCT07796568 - No phaseTaking peoplePiloting an Insomnia Treatment in Patients With Ulcerative Colitis
- Where
- Lebanon
- Age
- 18 years and over
- People
- 20
- Run by
- Dartmouth-Hitchcock Medical Center
See details and how to joinNCT07428629 - Phase 3Taking peopleStudy to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis
- Where
- Chula Vista, Nashville
- Age
- 18 years to 75 years
- People
- 150 worldwide
- Run by
- Vanda Pharmaceuticals
See details and how to joinNCT07686081 · EU 2025-524520-22-00